Medicare C-SNP enrollment improves kidney disease outcomes: study
By
Alicia Lasek
Nov 03, 2020
Adults with end-stage renal disease appear to have lower rates of hospitalization and mortality when they enroll in Medicare’s Chronic Condition Special Needs Plans, a new investigation has found.
Feds struggle to provide COVID-19 tally for nursing homes: report
By
Alicia Lasek
May 09, 2020
Weeks after CMS announced it would begin tracking outbreaks and deaths in the nation’s eldercare facilities, there are no solid numbers available, say investigators.
25 percent of COVID patients have post-acute symptoms; Report highlights emerging care needs
By
Alicia Lasek
Jun 18, 2021
A analysis based on nearly two million private U.S. healthcare claims has identified the most common post-COVID conditions with a focus on age, gender, mental health conditions and mortality. Even 19%...
Most senior living facilities short on coronavirus-fighting supplies, survey finds
By
Alicia Lasek
Mar 17, 2020
More than two-thirds of the nation’s senior living facilities report trouble sourcing equipment, particularly N95 respirators.
Ambien alternative? FDA approves insomnia drug that improves sleep in seniors
By
Alicia Lasek
Jan 01, 2020
New insomnia medication lemborexant compared favorably to an extended release form of Ambien in a late-stage clinical trial.
Feds identify promising and ‘urgently needed’ COVID antiviral drug
By
Alicia Lasek
Jun 04, 2021
The experimental drug TEMPOL has shown promise in early studies, halting the activity of a viral enzyme and limiting the severity of SARS-CoV-2 infections.
In-home COPD management program cuts 30-day acute-care readmissions
By
Alicia Lasek (f3)
Jun 29, 2022
Thirty-day readmission rates were 12% for post-acute COPD participants in an at-home pulmonary rehab program, and 22% for those without the intervention, a new study finds.
BREAKING: CMS increases oversight of nursing home survey process and expands nursing home visitation...
By
Kimberly Marselas
Danielle Brown
Nov 12, 2021
Nursing homes should allow visitation for residents “at all times,” while state surveyors received steps on how to address a backlog of complaint and recertification surveys under two separate memos...
Remdesivir effective against COVID-19, researchers conclude
By
Alicia Lasek
Oct 13, 2020
Intravenous remdesivir shortens recovery time and reduces mortality in hospitalized patients when compared to placebo, according to final trial data from NIAID. No other antiviral has yet been confirmed...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...